Skip to main content

Table 1 The H19 and IGF2-P4 overall expression in TCC tissue samples determined by RT-PCR (n = 39) and by in situ hybridization (ISH) (n = 28)

From: Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences

  RT-PCR ISH Total
IGF2-P4 38/39 24/28 62/67
H19 37/39 27/28 64/67